BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23019303)

  • 1. Integrity of the blood-testis barrier in healthy men after suppression of spermatogenesis with testosterone and levonorgestrel.
    Ilani N; Armanious N; Lue YH; Swerdloff RS; Baravarian S; Adler A; Tsang C; Jia Y; Cui YG; Wang XH; Zhou ZM; Sha JH; Wang C
    Hum Reprod; 2012 Dec; 27(12):3403-11. PubMed ID: 23019303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin suppression in men leads to a reduction in claudin-11 at the Sertoli cell tight junction.
    McCabe MJ; Tarulli GA; Laven-Law G; Matthiesson KL; Meachem SJ; McLachlan RI; Dinger ME; Stanton PG
    Hum Reprod; 2016 Apr; 31(4):875-86. PubMed ID: 26908839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levonorgestrel enhances spermatogenesis suppression by testosterone with greater alteration in testicular gene expression in men.
    Lue Y; Wang C; Cui Y; Wang X; Sha J; Zhou Z; Xu J; Wang C; Hikim AP; Swerdloff RS
    Biol Reprod; 2009 Mar; 80(3):484-92. PubMed ID: 19074003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception.
    Kamischke A; Plöger D; Venherm S; von Eckardstein S; von Eckardstein A; Nieschlag E
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):43-52. PubMed ID: 10931079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. transient scrotal hyperthermia and levonorgestrel enhance testosterone-induced spermatogenesis suppression in men through increased germ cell apoptosis.
    Wang C; Cui YG; Wang XH; Jia Y; Sinha Hikim A; Lue YH; Tong JS; Qian LX; Sha JH; Zhou ZM; Hull L; Leung A; Swerdloff RS
    J Clin Endocrinol Metab; 2007 Aug; 92(8):3292-304. PubMed ID: 17504903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
    Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
    J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in chinese men.
    Gui YL; He CH; Amory JK; Bremner WJ; Zheng EX; Yang J; Yang PJ; Gao ES
    J Androl; 2004; 25(5):720-7. PubMed ID: 15292101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment, maintenance and functional integrity of the blood-testis barrier in organotypic cultures of fresh and frozen/thawed prepubertal mouse testes.
    Rondanino C; Maouche A; Dumont L; Oblette A; Rives N
    Mol Hum Reprod; 2017 May; 23(5):304-320. PubMed ID: 28333312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
    Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist.
    Matthiesson KL; Amory JK; Berger R; Ugoni A; McLachlan RI; Bremner WJ
    J Clin Endocrinol Metab; 2005 Jan; 90(1):91-7. PubMed ID: 15509637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis of testis biopsies in men treated with injectable testosterone undecanoate alone or in combination with oral levonorgestrel as potential male contraceptive.
    Cui Y; Zhu H; Zhu Y; Guo X; Huo R; Wang X; Tong J; Qian L; Zhou Z; Jia Y; Lue YH; Hikim AS; Wang C; Swerdloff RS; Sha J
    J Proteome Res; 2008 Sep; 7(9):3984-93. PubMed ID: 18702538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen.
    Coviello AD; Bremner WJ; Matsumoto AM; Herbst KL; Amory JK; Anawalt BD; Yan X; Brown TR; Wright WW; Zirkin BR; Jarow JP
    J Androl; 2004; 25(6):931-8. PubMed ID: 15477366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of progestin and the progesterone receptor in the suppression of spermatogenesis in rodents.
    Lue Y; Wang C; Lydon JP; Leung A; Li J; Swerdloff RS
    Andrology; 2013 Mar; 1(2):308-17. PubMed ID: 23408752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men.
    Matthiesson KL; Stanton PG; O'Donnell L; Meachem SJ; Amory JK; Berger R; Bremner WJ; McLachlan RI
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5647-55. PubMed ID: 16030154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
    Behre HM; Nashan D; Hubert W; Nieschlag E
    J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethnic differences in testicular structure and spermatogenic potential may predispose testes of Asian men to a heightened sensitivity to steroidal contraceptives.
    Johnson L; Barnard JJ; Rodriguez L; Smith EC; Swerdloff RS; Wang XH; Wang C
    J Androl; 1998; 19(3):348-57. PubMed ID: 9639052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.
    Anawalt BD; Herbst KL; Matsumoto AM; Mulders TM; Coelingh-Bennink HJ; Bremner WJ
    Fertil Steril; 2000 Oct; 74(4):707-14. PubMed ID: 11020511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular heat exposure enhances the suppression of spermatogenesis by testosterone in rats: the "two-hit" approach to male contraceptive development.
    Lue Y; Hikim AP; Wang C; Im M; Leung A; Swerdloff RS
    Endocrinology; 2000 Apr; 141(4):1414-24. PubMed ID: 10746645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
    Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM
    J Androl; 2005; 26(3):405-13. PubMed ID: 15867009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.